Healthcare Industry News: kidney disease
News Release - March 23, 2011
Baxter Appoints James Saccaro as Treasurer and Corporate OfficerDEERFIELD, Ill.--(Healthcare Sales & Marketing Network)-- Baxter International Inc. (NYSE:BAX ) announced today that its Board of Directors has elected James K. Saccaro as treasurer and a corporate officer of the company.
Saccaro assumes the treasurer role from Robert J. Hombach, who was named the companyís chief financial officer in 2010. Most recently, Saccaro had served as vice president of strategy for Baxter. He joined the company in 2002 as manager of strategy for the companyís BioScience business, and over the years assumed positions of increasing responsibility, including vice president of financial planning, and vice president of finance for the companyís operations in Europe, Middle East and Africa. Prior to joining Baxter, he held strategy and business development positions at Clear Channel Communications and the Walt Disney Company. Saccaro received a bachelorís degree in economics and masterís degree in Engineering-Economic Systems from Stanford University.
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.
Source: Baxter International
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.